Back

Catheter ablation for atrial fibrillation in very young patients

24 April 2021 (14:30 - 15:25)
Organised by:
Congress Presentation Part of: Towards improved outcome of atrial ablation II Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Kivanc Yalin

Istanbul University Cerrahpasa, Istanbul (Turkiye)

6 More presentations in this session

Presentation thumbnail
Sex differences in mapping and rhythm outcomes of a repeat atrial fibrillation ablation
Doctor J. Park (Yongin, KR)
Abstract Slides Video
Presentation thumbnail
Ablation Index-guided 50W radiofrequency ablation for atrial fibrillation: lesion level analysis to ascertain determinants of safety
Doctor W. Ding (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Left atrial scar burden in sinus rhythm differs from atrial fibrillation using automated voltage analysis during radiofrequency ablation for atrial fibrillation
Doctor J. Mannion (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence-predicted poor responders to catheter ablation for atrial fibrillation
Doctor J. Park (Yongin, KR)
Abstract Slides Video
Presentation thumbnail
Predictive value of ten risk scores for outcomes of atrial fibrillation patients undergoing radiofrequency pulmonary vein isolation
Mr M. Mulder (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Towards improved outcome of atrial ablation II

The Event

Event poster

EHRA 2021

24 April 2021 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcome of catheter ablation for paroxysmal atrial fibrillation in very elderly patients: a propensity score-matched analysis
12 April 2026
thumbnail
Webinar
EHRA Webinar : How to perform safe and effective catheter ablation in the pediatric population
1 October 2018
thumbnail
Congress Presentation
Alcohol septal ablation is safe in young patients
30 June 2021
thumbnail
Congress Presentation
Exploring arrhythmias in children, adolescents and young adults with cancer: the Rebuc study perspective.
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources